Proven Regenerative Medicine Leader
Samuel Lynch, DMSc, DMD
Founder / Chairman / CEO
Double doctorates:
-
Harvard medical sciences and periodontal medicine.
Vanderbilt University Medical Center (VUMC) & Nashville Biosciences (NB):
-
Founding member Board of Directors of independent VUMC & NB
-
Chair of Audit and Compliance Committee - VUMC (5 years)
-
Chair of Compensation and Leadership Committee - VUMC (3 years)
​
Internationally recognized expert in regenerative medicine:
-
>200 patents and publications
-
Hundreds of invited lectures in 25+ countries
​
3-time Founder & CEO (all highly successful exists):
-
Osteohealth Co.
-
Now a division of Geistlich Pharma
-
-
BioMimetic Therapeutics [Nasdaq: BMTI]
-
IPO then trade sale, Now a division of Stryker, Inc.​
-
-
Lynch Biologics, LLC.​
-
Private sale to Geistlich Pharma NA for undisclosed amount​​​
-
​​
Southeast Medical Device Association Entrepreneur of the Year
Executive Leadership
Finance
Manufacturing
Regulatory
Quality systems
Skin Rejuvenation / Facial Aesthetics
-
Sales to Aesthetic Providers
-
Marketing
-
Direct Pay
Skin Regeneration / Wound Care
-
Sales to wound care clinics, hospitals, podiatrists
-
Marketing
-
Reimbursement
Our Medical Advisors & Investigators
Technology has been Developed in Collaboration with Scientists from Around the World…
Below are the Clinical Investigators Committed to Performing the Next Clinical Trials